ID

37648

Beschrijving

Study ID: 104864/612 Clinical Study ID: 104864/612 Study Title: A Prospective, Open Label Phase II Study to Evaluate the Efficacy and Safety of Topotecan (HycamtinTM) in Combination with Carboplatin as First-line Chemotherapy in Patients with Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: HycamtinTM Study Indication: Ovarian Cancer

Trefwoorden

  1. 13-08-19 13-08-19 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

13 augustus 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Topotecan (HycamtinTM) with Carboplatin as First-Line Chemotherapy in Patients with Ovarian Cancer; 104864/612

  1. StudyEvent: ODM
    1. Cycle 7
Administrative Data
Beschrijving

Administrative Data

Alias
UMLS CUI-1
C1320722
Patient Number
Beschrijving

Patient number

Datatype

integer

Alias
UMLS CUI [1]
C1830427
Day 1-5
Beschrijving

Day 1-5

Alias
UMLS CUI-1
C0008976
UMLS CUI-2
C0449438
Has the cycle been delayed?
Beschrijving

Clinical Trials, Delay of chemotherapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1299577
If Yes, please document the reason
Beschrijving

Clinical Trials, Delay of chemotherapy, Reason and justification

Datatype

text

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1299577
UMLS CUI [1,3]
C0566251
Please specify
Beschrijving

Clinical Trials, Delay of chemotherapy, Reason and justification

Datatype

text

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1299577
UMLS CUI [1,3]
C0566251
Administration of study medication topotecan (oral)
Beschrijving

Administration of study medication topotecan (oral)

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0146224
UMLS CUI-3
C3469597
Day
Beschrijving

Experimental drug, Topotecan, Administration of medication, Day

Datatype

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C3469597
UMLS CUI [1,4]
C0439228
Date
Beschrijving

Experimental drug, Topotecan, Administration of medication, Date in time

Datatype

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C3469597
UMLS CUI [1,4]
C0011008
Planned daily dose for this cycle
Beschrijving

Experimental drug, Topotecan, Daily Dose, Planned

Datatype

text

Maateenheden
  • mg/m2
Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C2348070
UMLS CUI [1,4]
C1301732
Administered dose for this cycle
Beschrijving

Experimental drug, Topotecan, Dosage

Datatype

integer

Maateenheden
  • mg
Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0178602
mg
Administration of study medication topotecan (oral)
Beschrijving

Administration of study medication topotecan (oral)

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0146224
UMLS CUI-3
C3469597
Capsules dispensed on
Beschrijving

Experimental drug, Topotecan, Dispense, Date in time

Datatype

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C1880359
UMLS CUI [1,4]
C0011008
Number of 1 mg capsules
Beschrijving

Experimental drug, Topotecan, Capsule, Dispensed Amount

Datatype

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C0805077
Number of 0,25 mg capsules
Beschrijving

Experimental drug, Topotecan, Capsule, Dispensed Amount

Datatype

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C0805077
Capsules returned by the patient on
Beschrijving

Experimental drug, Topotecan, Returned, Date in time

Datatype

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0332156
UMLS CUI [1,4]
C0011008
Number of 1 mg capsules
Beschrijving

Experimental drug, Topotecan, Capsule, Returned Amount

Datatype

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C2699071
Number of 0,25 mg capsules
Beschrijving

Experimental drug, Topotecan, Capsule, Returned Amount

Datatype

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C2699071
Has the dose been modified when compared to the previous cycle?
Beschrijving

Experimental drug, Topotecan, Medication dose changed

Datatype

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C1608430
If "yes", please document the reason
Beschrijving

Experimental drug, Topotecan, Medication dose changed, Reason and justification

Datatype

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C1608430
UMLS CUI [1,4]
C0566251
Please specify
Beschrijving

Experimental drug, Topotecan, Medication dose changed, Reason and justification

Datatype

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C1608430
UMLS CUI [1,4]
C0566251

Similar models

  1. StudyEvent: ODM
    1. Cycle 7
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Patient number
Item
Patient Number
integer
C1830427 (UMLS CUI [1])
Item Group
Day 1-5
C0008976 (UMLS CUI-1)
C0449438 (UMLS CUI-2)
Clinical Trials, Delay of chemotherapy
Item
Has the cycle been delayed?
boolean
C0008976 (UMLS CUI [1,1])
C1299577 (UMLS CUI [1,2])
Item
If Yes, please document the reason
text
C0008976 (UMLS CUI [1,1])
C1299577 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Code List
If Yes, please document the reason
CL Item
hematological AE (1)
CL Item
non-hematological AE (2)
CL Item
Other, please specify (3)
Item
Please specify
text
C0008976 (UMLS CUI [1,1])
C1299577 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Item Group
Administration of study medication topotecan (oral)
C0304229 (UMLS CUI-1)
C0146224 (UMLS CUI-2)
C3469597 (UMLS CUI-3)
Item
Day
text
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C3469597 (UMLS CUI [1,3])
C0439228 (UMLS CUI [1,4])
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
Experimental drug, Topotecan, Administration of medication, Date in time
Item
Date
date
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C3469597 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Item
Planned daily dose for this cycle
text
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C2348070 (UMLS CUI [1,3])
C1301732 (UMLS CUI [1,4])
Code List
Planned daily dose for this cycle
CL Item
Baseline (1)
CL Item
Day 1 (2)
CL Item
Day 8 (3)
CL Item
Day 15 (4)
Experimental drug, Topotecan, Dosage
Item
Administered dose for this cycle
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
Item Group
Administration of study medication topotecan (oral)
C0304229 (UMLS CUI-1)
C0146224 (UMLS CUI-2)
C3469597 (UMLS CUI-3)
Experimental drug, Topotecan, Dispense, Date in time
Item
Capsules dispensed on
date
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C1880359 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsule, Dispensed Amount
Item
Number of 1 mg capsules
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C0805077 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsule, Dispensed Amount
Item
Number of 0,25 mg capsules
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C0805077 (UMLS CUI [1,4])
Experimental drug, Topotecan, Returned, Date in time
Item
Capsules returned by the patient on
date
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0332156 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsule, Returned Amount
Item
Number of 1 mg capsules
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C2699071 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsule, Returned Amount
Item
Number of 0,25 mg capsules
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C2699071 (UMLS CUI [1,4])
Experimental drug, Topotecan, Medication dose changed
Item
Has the dose been modified when compared to the previous cycle?
boolean
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C1608430 (UMLS CUI [1,3])
Item
If "yes", please document the reason
text
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C1608430 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
CL Item
hematological AE (1)
CL Item
non-hematological AE (2)
CL Item
Other, please specify (3)
Experimental drug, Topotecan, Medication dose changed, Reason and justification
Item
Please specify
text
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C1608430 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial